Market Capitalization (Millions $) |
37 |
Shares
Outstanding (Millions) |
82 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-36 |
Cash Flow (TTM) (Millions $) |
-9 |
Capital Exp. (TTM) (Millions $) |
0 |
Nrx Pharmaceuticals Inc
Nrx Pharmaceuticals Inc is a pharmaceutical company that focuses on developing innovative therapies for various medical conditions. They specialize in the research and development of neurology and psychiatry drugs. The company aims to improve the lives of patients suffering from neurological disorders such as epilepsy, Parkinson's disease, and psychiatric conditions like schizophrenia and depression. Nrx Pharmaceuticals Inc strives to discover novel treatments and bring them to the market to provide better healthcare options to individuals in need.
Company Address: 1201 Orange Street Wilmington 19801 DE
Company Phone Number: 254-6134 Stock Exchange / Ticker: NASDAQ NRXP
NRXP is expected to report next financial results on March 30, 2024. |
|
|